The EveryLife Foundation for Rare Diseases is a 501(c)(3) nonprofit that works with patient organizations, academic scientists, the Food and Drug Administration (FDA), and National Institutes of Health (NIH) to improve the clinical development process in order to accelerate biotech innovation for rare disease treatments.